Lv1
20 积分 2023-05-11 加入
IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies
1个月前
已完结
A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease
1个月前
已完结
Response and Resistance to BCR-ABL1-Targeted Therapies
2个月前
已完结
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
2个月前
已完结
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
2个月前
已完结
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
2个月前
已关闭
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
2个月前
已关闭
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
2个月前
已关闭
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
2个月前
已关闭
Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signaling
2个月前
已关闭
皖公网安备34019202002308
